Roche inks $200M pact for Freenome's cancer screening blood test - Fierce Biotech
#Fierce Biotech#Freenome cancer#Roche inks#cancer screening#screening blood
Life Science News
Latest updates from the biotech and pharma world
Friday Five — Oral SERDs eye earlier opportunities, Agios' SCD miss, Avadel's not-so-sleepy bidding war…and more - FirstWord Pharma
#Agios' SCD#SCD miss#Oral SERDs#bidding war#earlier opportunities
Roche inks deal for rights to Freenome cancer tests outside US - MedTech Dive
#Freenome cancer#Roche inks#MedTech Dive#inks deal#cancer tests
Regeneron wins 2 Eylea nods, ramping up competition with Roche - Fierce Pharma
#Eylea nods#Fierce Pharma#Regeneron wins#Roche Fierce#Pharma Regeneron
UBS Sticks to Its Buy Rating for Roche Holding AG (RHHVF) - The Globe and Mail
#Buy Rating#Roche Holding#UBS Sticks#Mail UBS#RHHVF
Freenome teams up with Roche for cancer screening tests - MobiHealthNews
#Freenome teams#cancer screening#screening tests#Roche#MobiHealthNews Freenome
Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution (NASDAQ:OLMA) - Seeking Alpha
#Shares Double#MBC Data#Preach Caution#Seeking Alpha#Roche MBC
How one veteran strategist says to invest as bubbles in AI and credit may already be bursting - Business Insider
#Business Insider#veteran strategist#bursting Business#Business#Insider
C. Light Named One of Five Selected Projects in the Roche MS Innovation Challenge - Yahoo Finance
#Light Named#Selected Projects#Innovation Challenge#Yahoo Finance#Challenge Yahoo
Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests - Yahoo Finance
#providing Roche#Yahoo Finance#Roche access#billion lateral#future molecular
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Yahoo Finance
#Immunotherapeutics Announces#Announces Clinical#Clinical Trial#Trial Collaboration#Supply Agreement
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Yahoo Finance
#Rethinks Competitive#Competitive Edge#Breast Cancer#Cancer Trial#Olema Pharmaceuticals
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status - Morningstar Canada
#Breast Cancer#Cancer Drug#Drug Candidate#Candidate Giredestrant#Giredestrant Support
Freenome and Roche partner on cancer screening technology for ex-US markets - Medical Device Network
#Medical Device#Device Network#Roche partner#cancer screening#screening technology
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma - Yahoo Finance
#Yahoo Finance#European Commission#Commission approves#approves Roche#Lunsumio subcutaneous
Roche Had A Positive Cancer Study — And Its Rival Flew 130% - Investor's Business Daily
#Cancer Study#Rival Flew#Investor Business#Positive Cancer#Business Daily
Roche pill notches win in early breast cancer - BioPharma Dive
#Roche pill#BioPharma Dive#pill notches#notches win#early breast
Roche's oral SERD notches second pivotal breast cancer win - FirstWord Pharma
#oral SERD#SERD notches#Roche oral#FirstWord Pharma#pivotal breast
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits
#Stock Doubles#Roche Cancer#Cancer Drug#Drug Trial#Trial Yields
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial - Fierce Biotech
#Fierce Biotech#oral SERD#hitting goal#adjuvant breast#Roche oral